Лотиланер

Lotilaner (CAS 1398609-39-6) is a systemic isoxazoline ectoparasiticide developed for veterinary use, primarily in dogs and cats. It acts by inhibiting GABA- and glutamate-gated chloride channels, leading to rapid paralysis and death of fleas and ticks. This compound is characterized by its high potency and prolonged duration of action, making it a preferred choice in oral formulations for ectoparasite control.

We supply Lotilaner as a white to off-white powder with a purity of ≥98% (HPLC), suitable for pharmaceutical formulation and veterinary product development. Each batch is accompanied by a COA, MSDS, and TDS, ensuring traceability and compliance with regulatory standards.

Синонимы: Lotilaner, 4-[(5RS)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(4-methoxyphenyl)methyl]-2-methylbenzamide

Приложения

• Veterinary oral solutions for flea and tick control in dogs and cats
• Combination products with other antiparasitic agents
• R&D for novel ectoparasiticide formulations

Качество и документация

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request. Stability data can be provided to support your qualification and registration processes.

Упаковка и поставки

Standard packaging: 1 kg, 5 kg, and 25 kg; bulk and custom packing available. In-stock items ship within 3-5 days; MOQ from 1 kg. For pricing, samples, and bulk orders, contact our sales team.

Запрос Цитировать

• Наш адрес: 280 Main Street, Сиань, провинция Шэньси, Китай
• LyvBio Co., Ltd. — Электронная почта: info@lyvbio.com